Influenza and Vaccines - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Influenza and Vaccines

Description:

Removes the sialic acid from the cell receptor after the virus has attached to it ... Prevents neuraminidase from cleaving sialic acid during budding ... – PowerPoint PPT presentation

Number of Views:60
Avg rating:3.0/5.0
Slides: 19
Provided by: MICHELLE6
Category:

less

Transcript and Presenter's Notes

Title: Influenza and Vaccines


1
Influenza and Vaccines
2
History
  • Influenza has been described as early as 400 B.C.
  • Major epidemics and pandemics of influenza have
    occurred throughout history.
  • The influenza pandemic of 1918 led to 20,0000,000
    deaths worldwide
  • Many virologists think another influenza pandemic
    that could kill millions of humans is inevitable.

3
Epidemiology
  • Epidemics become unmanageable at alarming speeds
    because
  • Short incubation period (1-4 days)
  • One droplet can contain 100,000 to 1,000,000
    virus particles.
  • Symptomatic people do not stay home spread.
  • Lack of herd immunity
  • Absenteeism from schools is the best indicator of
    the scale of an epidemic.

4
Influenza Statistics
  • 1957-1987 There were 20 influenza epidemics
    recorded in the U.S.
  • 36,000-50,000 people have died as a direct or
    indirect consequence of an influenza infection
  • Lets take a look at the statistics for previous
    year
  • Update - Influenza Activity, United States
    September 28, 2008 - January 31, 2009

5
Influenza Virus
  • Ss RNA Virus
  • Segmented (8 strands)
  • Enveloped spikes proteins
  • H - attachment N - escape (sialidase)

6
Influenza Virus
7
Influenza A Virus Particle
  • Hemagglutinin (H)
  • Glycoprotein which binds to cell receptors
  • Main antigen against which neutralizing antibody
    is formed
  • Neuraminidase (N
  • Removes the sialic acid from the cell receptor
    after the virus has attached to it
  • Decreases the viscosity of respiratory tract
  • Helps virus spread in the respiratory tract

Figure 12.6c the influenza A virus structures
D, H, and N spikes.
8
Influenza Virus
  • Orthomyxovirus
  • Strains A, B and C
  • Strain A and Hemagluttinin and Neuraminidase
  • Influenza A (H5N1) virus - bird flu
  • Influenza A (H1N1, H1N2, and H3N2) - commonly
    circulating in humans

9
Virus Evolution
  • Have you ever gotten the flu shot one year and
    still came down with the flu?
  • Why?
  • Antigenic shift
  • 2 strains and exchange of genes to make new
    strain
  • Antigenic drift
  • Mutation in one strain to make new strain
  • New strains every year
  • Need a new shot every year

10
Antigenic Drift
  • Responsible for seasonal influenza strains

Figure 12.13a Antigenic drift is the gradual
accumulation of new epitopes on the H protein
(and, to a lesser degree, the N protein).
Adapted from Annenberg Media. Emerging
Infectious Diseases. Rediscovering Biology
Molecular to Global Perspectives. Annenberg
Media, 1997. http//www.learner.org/channel/course
s/biology/textbook/infect.
11
Antigenic Shift
  • Responsible for Pandemic strains
  • When two types of influenza infect the cell
  • Reassortment of the RNA pieces can occur

Figure 12.13b Antigenic shift occurs when the
influenza A virus acquires a new H or N gene.
12
Influenza (Flu)
  • Etiology influenza virus
  • Symptoms
  • Early headache, malaise, congestion, sore
    throat, swollen lymph nodes, fatigue
  • Peak Fever, severe congestion, myalgia,
    rhinitis, cough
  • Adult known severe symptoms with risk factors
  • Fluid accumulation in lungs which can lead to
    pneumonia and or breathlessness and wheezing
  • Vomiting and weight loss
  • Severe fever (above 102)
  • Symptoms in children
  • Febrile seizures with high fever
  • Vomiting
  • Ear infection
  • Recovery
  • 7 to 10 days for healthy individuals
  • 2 to 5 weeks in those with risk factors
  • Death occurs more often in those with risk factors

13
Risk Factors
  • Weakened immunity
  • Age
  • Young (under 2) and elderly (above 60) have
    ineffective immune system
  • Smoking
  • pulmonary defense system weak
  • Uncontrolled diabetes
  • Asthma
  • Pregnancy
  • Heart disease
  • Immunosuppressant therapy
  • Cancer, tissue transplants

14
Vaccine
  • Injection of antigen
  • Whole agent
  • Inactivated versus live attenuated
  • Subunit
  • Toxoid
  • Immune response
  • B cell activation and antibody production?Short
    term immunity
  • Memory cell production?Long term immunity

15
Influenza Vaccine
  • Inactivated Whole Agent
  • Mixture of a few influenza strains
  • Strains chosen based on the most abundant strains
    infecting Asian populations the previous year.
  • Immunity from vaccine or recovery from actual
    disease
  • Herd Immunity
  • 70 of the population immune (vaccine or active
    disease)
  • Dramatically slows spread (ex. Small pox)
  • What percentage of the population actually gets
    vaccinated?
  • Who SHOULD be vaccinated?

16
Vaccination
17
Vaccine Efficacy
  • Not always 100 effective
  • Herd Immunity difficult to achieve
  • Reasons why
  • You are vaccinated for a specific strain and any
    new strain can still infect you
  • New strains and genetic drift and shift
  • If you have a weak immune system you dont always
    have a strong immune response to protect you
  • So why bother?
  • Who should bother?

18
More Protection
  • Prevent exposure
  • Hand washing
  • Dont really need antimicrobial soap! Any soap
    will do.
  • Common Sense
  • Antivirals MUST BE TAKEN EARLY
  • Amantadine, Rimantadine
  • Prevent uncoating
  • Zanamivir (Relenza), and Oseltamivir (Tamiflu)
  • Prevents neuraminidase from cleaving sialic acid
    during budding
  • Causes viruses to clump at the cell surface,
    reducing viral spread
  • There are NO antibiotics!
Write a Comment
User Comments (0)
About PowerShow.com